Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mary Szela Insider Profile
4 Followers
Mary Szela, Director at Receptos, holds 0.00 shares in Receptos (Ticker: RCPT), holds 0.00 shares in Aegerion (Ticker: AEGR), holds ― shares in Novelion Therapeutics (Ticker: NVLNF).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-0.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mary Szela holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 24, 2020 - Jun 24, 2021
Return:+11.00%
The most profitable trade made by Mary Szela
Mary Szela's Trading History
Receptos
Aug 27, 2015
―
Uninformative Sell
―
$0.00
Aegerion
―
―
―
$0.00
Novelion Therapeutics
―
―
―
―
Coherus Biosciences
Jun 24, 2020
Director
Uninformative Buy
485.89K
$0.00
Alimera
―
―
―
―
Kura Oncology
―
Director
―
―
Prometheus Biosciences
Jun 16, 2023
―
Uninformative Sell
―
$0.00
Omega Therapeutics
―
Director
―
―
TriSalus Life Sciences
Sep 13, 2024
CEO & President, Director
Informative Buy
75.36K
$1.57M
Abbott Laboratories
Dec 16, 2011
SVP
Informative Buy
2.85M
$14.11M
List of latest transactions for each holding click on a transaction to see Mary Szela's performance on stock
You May Also Like
Mary Szela insider profile FAQ
What is the percentage of profitable transactions made by Mary Szela?
The percentage of profitable transactions made by Mary Szela is 67%.
What is the average return per transaction made by Mary Szela?
The average return per transaction made by Mary Szela is -0.20%.
What stocks does Mary Szela hold?
Mary Szela holds: RCPT, AEGR, NVLNF, CHRS, ALIM, KURA, RXDX, OMGA, TLSI, ABT stocks.
What was Mary Szela’s latest transaction?
Mary Szela latest transaction was an Uninformative Sell of ―.
What was Mary Szela's most profitable transaction?
Mary Szela’s most profitable transaction was an Informative Sell of CHRS stock on June 24, 2020. The return on the trade was 11.00%.
What is Mary Szela's role in Receptos?
Mary Szela's role in Receptos is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.